IW Homepage Web Watch Resources Web Links Thought Leaders Site Search Contact Us
About Newsletter Contributors Multimedia Clips Futurepedia Podcast David Forrest's Blog
Join the Innovation Watch community... read and post in our online forums (coming soon) Innovation Forums
   Books on the Future and Emerging Trends -
   Bio and Nanotechnology
 HOME
 Resources
 The Future and
 Emerging Trends
 
 Foresight
 Science
 Technology
 Society
 Economy
 Global Politics
 Environment
 Possible Futures
 Making Change

From Alchemy to IPO: The Business of Biotechnology
by Cynthia Robbins-Roth

Cambridge, Massachusetts: Perseus Publishing, 2000

It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen, and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new solutions and innovative treatments. It describes in vivid detail the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market, and describes advances, such as deciphering the genetic code and gene therapy, that have the potential to lead biotech to a higher realm altogether.

This is the first book to accurately record the inner working of an industry that's on the verge of living up to its monumental promise to change the world as we know it. Through compelling stories and first hand interviews, it describes what really drives the people and the products. It also examines from the inside the management practices that have led to enormous profit, and identifies the ingredients that make a successful biotech company different.

Cynthia Robbins-Roth -- Forbes columnist, biotech industry consultant and entrepreneur, and former Genentech scientist -- untangles the inextricable relationship between science and profit. With anecdotes and first-hand insight she chronicles the biotech revolution -- from the laboratory to the boardroom to harnessing the elusive potential of biotech stocks.

An invaluable resource for investors, entrepreneurs and anyone interested in biotechnology's significant promise, From Alchemy to IPO presents the information every one of us needs to understand and profit in a sector that's rich with opportunity and risk.

Cynthia Robbins-Roth, Ph.D., is the founder of BioVenture Consultants, which provides strategic planning and technical/business assessment to the biotech industry. Her biotech column appears regularly in Forbes ASAP magazine, which named her one of the top 25 biotech All Stars of 1999 for her founding role in several of the key biotech industry business publications. She is author of Alternative Careers in Science and lives in San Mateo, California.

 
   
IW Homepage | Web Watch | Resources | Web Links | Thought Leaders | Site Search | Contact Us
About | Newsletter | Contributors | Multimedia Clips | Futurepedia | Podcast | David Forrest's Blog
Join the Innovation Watch community... read and post in our online forms: Innovation Forums
Send mail to mail (at) innovationwatch.com with questions or comments about this site.
Copyright © 2001-2009. Innovation Watch is a registered trademark.